• LAST PRICE
    0.0800
  • TODAY'S CHANGE (%)
    Trending Down-0.0050 (-5.8824%)
  • Bid / Lots
    0.0800/ 62
  • Ask / Lots
    0.0850/ 96
  • Open / Previous Close
    0.0800 / 0.0850
  • Day Range
    Low 0.0800
    High 0.0800
  • 52 Week Range
    Low 0.0700
    High 0.1350
  • Volume
    2,500
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 0.085
TimeVolumeMIR
09:32 ET10000.08
03:50 ET10000.08
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaMIR
MedMira Inc
61.3M
-18.0x
---
CanadaTLT
Theralase Technologies Inc
60.2M
-14.7x
---
CanadaPINK
Perimeter Medical Imaging AI Inc
40.6M
-1.8x
---
CanadaBLO
Cannabix Technologies Inc
45.0M
-11.7x
---
CanadaTRUE
Treatment.com AI Inc
28.0M
-2.2x
---
CanadaVPT
VentriPoint Diagnostics Ltd
22.6M
-4.4x
---
As of 2024-11-13

Company Information

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

Contact Information

Headquarters
155 Chain Lake Dr.,, Suite 1HALIFAX, NS, Canada B3S 1B3
Phone
902-450-1588
Fax
902-450-1580

Executives

Independent Chairman of the Board
Thomas Bergmann
Chief Executive Officer, Director
Hermes Chan
Chief Financial Officer
Markus Meile
Independent Director
Steven Cummings
Independent Director
Jianhe Mao

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$61.3M
Revenue (TTM)
$383.3K
Shares Outstanding
720.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$0.00
Book Value
$-0.02
P/E Ratio
-18.0x
Price/Sales (TTM)
159.8
Price/Cash Flow (TTM)
---
Operating Margin
-525.29%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.